Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients

Chiara Dentone, Antonio Di Biagio, Alessia Parodi, Federica Bozzano, Paolo Fraccaro, Alessio Signori, Giovanni Cenderello, Eugenio Mantia, Giancarlo Orofino, Andrea De Maria, Gilberto Filaci, Daniela Fenoglio

Research output: Contribution to journalArticlepeer-review

Abstract

This is a cross-sectional, case-control study analyzing the effect of antiretroviral therapy (ART) including or not maraviroc, on circulating monocytes and natural killer cells. Sixty-eight HIV-positive patients virologically suppressed receiving ART at least 6 months were subdivided as receiving (group 1) or not (group 2) maraviroc in their ART. Frequency of monocytes and natural killer cells, as well as their activation markers, were studied. Modulation of innate immune cells may be differently affected by combined ART.

Original languageEnglish
Pages (from-to)1071-1074
Number of pages4
JournalAIDS (London, England)
Volume28
Issue number7
DOIs
Publication statusPublished - Apr 24 2014

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases
  • Medicine(all)

Fingerprint Dive into the research topics of 'Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients'. Together they form a unique fingerprint.

Cite this